Pulmonology Month in Review: May 2024
This review of May 2024 covered several notable topics in the pulmonary health field, including research into vaping, lung abnormalities, and treatment of COPD.
Source: hcplive.com
Surya Bhatt News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Surya Bhatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Surya Bhatt Today - Breaking & Trending Today
Dr Surya Bhatt Highlights NOTUS Trial Findings, Promising Dupilumab Results
Surya Bhatt, MD, MSPH, of the University of Alabama at Birmingham, discussed the challenges of diagnosing chronic obstructive pulmonary disease (COPD) with type 2 inflammation, as well as the promising efficacy of dupilumab in treating this condition.
Source: ajmc.com
FDA Extends Dupilumab COPD Decision to September 2024
The FDA moved the target date for their decision on the dupilumab application by 3 months, citing a need for more efficacy data from its pivotal phase 3 trials.
Source: hcplive.com
Late-Breaking Data From Clinical Trials Show Promise for the Future of COPD Treatment
Study authors shared late-breaking data in a session on clinical trial results in pulmonary medicine at the American Thoracic Society 2024 International Conference.
Source: ajmc.com
Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation
Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -; dupilumab -; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine.
Source: news-medical.net